Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5773422

CC1CCCCN1CCCNC(=O)CCc1cnoc1-c1ccc(F)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 5/20 0.43
KDM4E B2RXH2 3/20 0.43
SLC2A1 P11166 1/20 0.43
CACNA1G O43497 3/20 0.42
TSHR P16473 4/20 0.41
HRH3 Q9Y5N1 2/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP3A4 P08684 2/20 0.40
ALDH1A1 P00352 1/20 0.40
USP2 O75604 1/20 0.40
LMNA P02545 1/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C19 P33261 2/20 0.40
THRB P10828 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5774863 0.93 HSD17B10 (0.43) HSD17B10KDM4ETSHRHRH3HTT
Trifluoroacetic Acid SCHEMBL5773355 0.84 TSHR (0.50) KDM4ETSHRHTTSMN1; SMN2ALDH1A1
Trifluoroacetic Acid SCHEMBL5773774 0.83 TSHR (0.41) KDM4ESLC2A1TSHRHRH3HTT
Trifluoroacetic Acid SCHEMBL5775671 0.83 TSHR (0.41) KDM4ESLC2A1TSHRHRH3HTT
Trifluoroacetic Acid SCHEMBL5774292 0.82 TSHR (0.50) KDM4ETSHRHTTSMN1; SMN2ALDH1A1
SCHEMBL5773426 0.81 ACHE (0.41) HSD17B10KDM4ESLC2A1CACNA1GTSHR
Trifluoroacetic Acid SCHEMBL5777111 0.79 CD274 (0.49) HSD17B10TSHRSMN1; SMN2USP2LMNA
Trifluoroacetic Acid SCHEMBL5773631 0.78 POLB (0.48) HTTSMN1; SMN2LMNAKMT2AMEN1
Trifluoroacetic Acid SCHEMBL5774893 0.78 GAA (0.47) TSHRHTTSMN1; SMN2ALDH1A1USP2
Trifluoroacetic Acid SCHEMBL5777437 0.77 ACKR3 (0.41) TSHRHTTSMN1; SMN2ALDH1A1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR HSD17B10 305/4885KDM4E 3953/4885SLC2A1 96/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 HSD17B10 194/4885KDM4E 3347/4885SLC2A1 47/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.